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ABSTRACT 
 
All mammals depend on oxygen in order to produce life-essential energy. They acquire 
oxygen (O2) through inspiration. In the lungs, O2 is gathered by erythrocytes that consequently 
deliver it to all cells by the cardiovascular system. O2 levels vary within our bodies. The 
highest levels are measured in the respiratory system and at lowest in the most peripheral 
parts of the body, for example skin. Therefore, the physiological levels of O2 are different in 
different tissues. During pathological events that result in challenged acquisition of O2, such 
as disturbances in the bloodstream or sudden increases of the cell numbers, the need of O2 
often becomes higher than the demand; a condition defined as hypoxia. Because of this, 
mammals have developed responses that help to manage hypoxia at different levels.  
Systemically, low O2 levels are sensed by chemoreceptors that activate a chain of reflexes 
leading to more efficient O2 delivery. Mammalian cells react to hypoxia by increasing O2 
independent energy production, which is done through glycolysis. Cells also activate 
signaling cascades that stimulate more efficient O2 delivery in their environment. Cellular 
reactions to low O2 are managed by hypoxia inducible factors (HIF), proteins that drive the 
expression of large amounts of genes necessary for survival in hypoxic environments.  
O2 sensing is important for all mammalian cell types, however it is particularly crucial for 
motile cells that move through different tissues with a variable O2 availability. Cells of the 
immune system need to function also in hypoxic environments. Mononuclear phagocytes 
(MP) are a group of multifunctional cells of the immune system that are highly dependent on 
HIF signaling and are also involved in numerous pathological conditions. Previous studies 
have shown that removal of HIF genes in MP results in dampened disease progression caused 
by environmental hypoxia, cancer or sepsis. Although the importance of HIF signaling in MP 
has been shown in several studies, very few of the studies describe the consequences of 
exaggerated HIF signaling in different states of diseases.  
The work in this thesis aims to understand the role of myeloid hypoxia in pulmonary edema, 
cancer and sepsis, that has been described in three different studies attached to this thesis 
book. We have shown that augmented hypoxic response in MPs is enough to induce high-
altitude pulmonary edema (HAPE)-like symptoms to such extent that it could be used as a 
model for studying pathological effects of environmental hypoxia in mice. In cancer, on the 
other hand, we showed that MP hypoxic response contributes to immune suppression by 
blocking cytotoxic lymphocyte proliferation. The MP-driven inhibition of lymphocyte 
proliferation occurred during antigen presentation, a process important for lymphocyte 
activation. Finally, in endotoxin induced sepsis, our studies demonstrated that removal of 
HIF-1α leads to decreased hypoglycemia due to reduced glycolysis. The strongest reduction 
in glycolysis was observed in the heart and brown fat.  
In conclusion, HIF signaling in MP plays a complex, yet important role in pathogenesis of 
several major diseases.  
  
SAMMANFATTNING 
 
Livet på jorden är beroende av syre. Däggdjuren använder andningen för att förse sitt blod med 
syre som sedan förs runt i kroppen med hjälp av hjärt- och kärlsystemet. Genom detta system 
blir varje cell i vår kropp försedd med syre. Olika delar i kroppen har olika mängder syre. En 
tumregel är att syremängden är högst i lungorna och lägst i de vävnader som är längst bort från 
de stora blodbanorna, till exempel huden. I detta avseende är normala syre-mängder relativa 
och vävnadsspecifika. Hypoxi är en term som används för att beskriva när syre i kroppen eller 
vävnaden är onormalt lågt. Oftast förorsakas hypoxi av en bakomliggande sjukdom. Sjukdomar 
som leder till skador i lungorna, blodkärlen eller en onaturlig ökad mängd celler i en vävnad är 
några exempel på hur vävnader blir hypoxiska.  
För många celler i vår kropp är anpassningen till hypoxi livsviktigt. Den cellulära anpassningen 
styrs genom proteiner som gemensamt kallas för hypoxi-inducerade faktorer (HIF). Denna 
anpassning är extra viktig för celler som måste röra sig mellan olika vävnader, speciellt för 
celler som tillhör vårt immunsystem. I denna avhandling studeras en grupp av celler från vårt 
immunsystem (myeloida celler). Studierna fokuserar på hur dessa celler anpassar sig till 
hypoxi, samt hur deras anpassning till hypoxi påverkar sjukdomar som lungödem, 
blodförgiftning samt cancer. Studierna är genomförda med hjälp av genetiska förändringar i 
myeloida celler, antingen genom att konstant höja nivåerna av HIF, eller genom att ta bort HIF. 
Avhandlingen är uppdelad i tre olika delar, där den första delen handlar om sjukdomen 
höghöjdslungödem (HAPE), något som drabbar bergsbestigare. Vanligtvis orsakas HAPE av 
kärlsammandragning i lungorna med inflammation som en påföljd. Här har våra studier visat 
att den myeloida hypoxin är tillräcklig för att ge upphov till HAPE-liknande symptom, och vi 
har utvecklat ett modellsystem för framtida studier om HAPE.  
I den andra studien utforskar vi en av mekanismerna som myeloida celler använder för att 
stoppa det adaptiva immunförsvaret från att bekämpa cancer. Vår forskning visar att myeloid-
specifik hypoxi stoppar de cytotoxiska cellerna från att aktiveras.  
Slutligen utforskar den sista studien hur det myeloida proteinet HIF-1α påverkar utvecklingen 
av endotoxininducerad blodförgiftning. Borttagning av HIF-1α i myeloida celler resulterar i 
minskad endotoxininducerad hypoglykemi samt förbättring av de kliniska symtomen 
relaterade till blodförgiftning. 
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1 INTRODUCTION: HYPOXIA AND MYELOID CELLS 
 
Oxygen (O2) levels within the human body are substantially different depending on the tissue. 
Highest levels are found in inspired air and lowest in our most peripheral tissues. As O2 is 
transferred from atmospheric air to the arterial blood, O2 levels will drop from 21% to 13.2%. 
The average level of O2 within tissues is approximately 5% (Figure 1), while in the skin O2 
levels are below 1%. (Carreau et al. 2011)  
   
 
Figure 1. Physiological levels of O2 are highly variable. Ranked by the highest to the lowest value, average levels 
of O2 for each tissue are represented as bar graphs, atmospheric air as a continuous line and the whole-body average 
as a dotted line. Data collected from Carreau et al. 2011 
 
Abnormally low O2 levels in tissues or organs defines hypoxia. Hypoxia is often a pathological 
condition caused by environmental factors (such as high altitude), pulmonary or cardiological 
pathologies, factors disturbing the blood flow or rapid increase in cellular density in tissues, 
that are usually caused by neoplastic events or by inflammation (Chao et al. 2009; Schwartz et 
al. 2011; McKeown 2014). O2 is vital for mammal life and therefore our bodies have developed 
complex responses to hypoxia, ranging from systematic reflexes to adaptations at cellular levels 
(Weir et al. 2005).  
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1.1 ACUTE RESPONSE TO HYPOXIA 
The systemic responses to hypoxia involve a complex signaling network from several 
chemoreceptor cells. Commonly these signaling pathways aim to compensate for decreased O2 
levels. This is achieved through regulations of pulmonary and vascular functions. O2 sensing 
occurs through three major chemoreceptor units localized in the lungs and carotid arteries. 
(Weir et al. 2005) 
In poorly ventilated regions of the lung, alveolar hypoxia leads to regional vascular constriction 
by the smooth muscle cells, also known as hypoxic pulmonary vasoconstriction (HPV) 
(Dunham-Snary et al. 2017). This process is meant to shuttle blood from poorly ventilated 
regions to the more ventilated ones to increase O2 availability (Dunham-Snary et al. 2017). 
Thereby, highly ventilated regions of the lung are also well perfused (Sylvester et al. 2012; 
Baumgardner & Hedenstierna 2016). The regulation of ventilation and perfusion matching is 
mainly conducted by vascular smooth muscle cells (VSMC) (Aaronson et al. 2005). Alveolar 
hypoxia initiates inhibition of the potassium channels, which in turn activates voltage gated 
calcium channels in the cellular membrane of VSMC (Aaronson et al. 2005). The influx of 
calcium in the cytosol lead to cellular depolarization and VSMC constriction (Aaronson et al. 
2005).  
As HPV is a local response to hypoxia, pulmonary neuroepithelial bodies initiate 
cardiorespiratory adjustments to hypoxia (Adriaensen et al. 2002). Airway hypoxia triggers 
depolarization of neuroepithelial bodies, which in turn stimulate the neurotransmission through 
the vagus nerve into the central nervous system (Adriaensen et al. 2006). This 
neurotransmission pathway also controls the heart rate (Ardell et al. 2015).  
Furthermore, disturbances in pulmonary ventilation and perfusion leads to decreased levels of 
arterial O2 (hypoxemia) (Rodríguez-Roisin & Roca 2005). Here, O2 sensing occurs in the 
carotid body, whose main function is to evoke hyperventilation (Lopez-Barneo et al. 2008). 
The carotid body is located at the branching point between internal and external carotid arteries 
(Nurse 2014).  It consists of mainly two cell types, glomus type I (chemoreceptor cells) and 
glomus type II (glial-like cells) (Nurse 2014). Decreased levels of the arterial O2 will then 
trigger depolarization of chemoreceptor cells within the carotid body, leading to their release 
of neurotransmitters and further neurotransmission (Lopez-Barneo et al. 2008; Nurse 2014). 
Collectively, depolarization of O2 sensitive chemoreceptors trigger events leading to 
hyperventilation, increased heart rate, venous return and cardiac output in order to increase the 
delivery of O2 to the peripheral tissues (Figure 2) (Siebenmann & Lundby 2015; Weir et al. 
2005). Where systemic reactions to hypoxia aim to make O2 delivery more efficient, the cellular 
response to hypoxia, on the other hand results in transcriptional activities that are essential for 
both enhanced oxygen delivery (e.g by production of erythropoiesis and angiogenesis) and 
adaptation to low O2 (Wilson et al. 2020).    
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Figure 2: Localization and function of different oxygen sensing chemoreceptors in the human body. V/Q: 
Ventilation/perfusion ratio. 
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1.2 HYPOXIA INDUCIBLE FACTORS 
The cellular response to O2 is driven by transcription factors called Hypoxia-Inducible Factors 
(HIF) (G. Semenza & Wang 1992). HIF consist of 3 alpha subunits (HIF-1α, HIF-2α and HIF-
3α) and the beta subunit and its binding partner, aryl hydrocarbon receptor nuclear translocator 
(ARNT) (Wang et al. 1995). Structurally HIF-1α and HIF-2α contain similar protein domains 
involved in DNA binding, heterodimerization with ARNT, O2 dependent degradation, nuclear 
translocation and coactivator binding domain (Figure 3) (Loboda et al. 2010; Hu et al. 2007). 
HIF-3α comes in different splice variants with different functions commonly lacking the C 
terminal transactivation domain (C-TAD) required for binding of chromatin remodeling 
coactivators P300/CBP (Gu et al. 1998).  
 
 
Figure 3: Simplified overview of different protein domains found in HIF-1α, HIF-2α, HIF-3α and the 
binding partner ARNT.  bHLH: Basic helix-loop-helix, PAS: Per-Arnt-Sim, ODD: Oxygen-dependent 
degradation domain, NLS: Nuclear localization sequence, C-TAD: C-terminal transactivation domain. 
 
HIFs are constitutively expressed (Salceda & Caro 1997) but are tightly regulated post 
transitionally through two oxygen-dependent pathways. Factor inhibiting HIF (FIH) controls 
HIF transcriptional activity by hydroxylation of a conserved asparagine residue in the C-TAD 
domain, therefore preventing the binding of P300/CBP (Lando et al. 2002). HIFs are also 
constantly degraded through proteasomal activity initiated by hydroxylation of prolines found 
in the O2 dependent degradation domain, catalyzed by prolyl hydroxylases (PHDs) (Hon et al. 
2002). The hydroxylated prolines are then recognized by the von Hippel-Lindau protein 
(VHL), which in turn drives HIFs to proteasomal degradation through polyubiquitination 
  5 
(Maxwell et al. 1999). The catalytic activities of FIH and PHDs are dependent on O2 as a 
substrate (Hirsilä et al. 2003; Ehrismann et al. 2006). Decreasing levels of O2 result in inactivity 
of FIH and PHDs, allowing HIF to translocate into the nucleus to form a dimer with ARNT 
(Figure 4). The dimerization results in chromatin remodeling by P300/CBP, DNA binding and 
initiation of transcriptional activity, through recognition and binding to hypoxia responsive 
elements (HRE). (Kaelin & Ratcliffe 2008)  
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1.3 HYPOXIA SENSITIVE GENES AND ADAPTATION TO CHRONIC HYPOXIA 
Transcriptional activity by HIFs is known to induce expression of a broad range of genes 
involved in angiogenesis, metabolic adaptations, proliferation and inflammation (Cummins et 
al. 2016; Dengler et al. 2013). HIF-3α consists of several different splice variants, which are 
known to function as negative regulators of HIF-1α and HIF-2α activity by competing for the 
binding partner ARNT (Duan 2016). Some studies demonstrate a full transcriptional activity 
for zebra fish variants of HIF-3α (P. Zhang et al. 2014). However, due to the extensive variation 
in splice variants between different species, full functional potential of HIF-3α is yet to be 
explored. HIF-1α and HIF-2α are structurally similar proteins with different roles in the cellular 
response to hypoxia (Hu et al. 2003; Loboda et al. 2010). In hypoxia, HIF-1α and HIF-2α 
stabilization is time dependent. Broadly, HIF-1α stabilization peaks within the first 24 hours of 
hypoxia followed by stabilization of HIF-2α, typically within 24-72 hours in hypoxia 
(Holmquist-Mengelbier et al. 2006; Reiterer et al. 2019). Time dependent stabilization of the 
two isoforms reflects the role in biological function; HIF-1α induces transcription of genes 
important for acute response to hypoxia, while HIF-2α induces expression of genes involved 
in adaptation to chronic hypoxia (S. A. Patel & Simon 2008).  
O2 is an essential substrate for mitochondrial driven oxidative phosphorylation and its 
production of the adenosine 5′-triphosphate (ATP) (Nath & Villadsen 2015). Nevertheless, as 
a cell enters hypoxia, their main source of energy becomes glycolysis, which generates ATP in 
an O2 independent manner (Robin et al. 1984). In mammals, upscaling of glycolysis is initiated 
through HIF-1α activity (Seagroves et al. 2001). To be able to increase the capacity for 
glycolysis and the ability to produce anaerobic ATP, HIF-1α drives expression of Hexokinases, 
Phosphoglycerate kinase-1, Fructose-1,6-biphosphatase-1, Pyruvate dehydrogenase kinase-1 
and Lactate dehydrogenase A (G. L. Semenza et al. 1994; Maxwell et al. 2001).  
Tissue hypoxia leads to increased production of nitric oxide (NO), a signaling molecule that 
induces vascular dilation (Mil et al. 2002; Casey et al. 2009). NO is produced by the nitric 
oxide synthase (NOS) from L-arginine (Epstein et al. 1993). The entry of NO into a VSMC 
leads to activation of guanylyl cyclase, an enzyme that drives production of cyclic guanosine 
monophosphate (cGMP).  cGMP then, in turn, shuts down potassium channels leading to 
calcium release and VSMC relaxation (Tropea et al. 2018). Signaling of NO occurs in paracrine 
matter due to its extremely short half time, 0.05-1.8 minutes in blood (X. Liu et al. 1998). 
Murine HIF-1α induces expression of inducible NOS (iNOS) and therefore increases the cell’s 
capacity to produce NO (Melillo et al. 1995; Palmer et al. 1998). In humans, iNOS and 
endothelial NOS (eNOS) are the inducible isoforms (Jung et al. 2013; Taylor & Geller 2000), 
although NO production in humans is known to be driven by hypoxia as well (Levett et al. 
2011). However, the direct link between HIF-1α and NOS is yet to be explored. In the 
endothelial cells, NO is known to induce endothelial cell permeability and their production of 
vascular endothelial growth factor (VEGF) (Durán et al. 2013; Kimura et al. 2000).  
VEGF expression is driven by both HIF-1α and HIF-2α (Forsythe et al. 1996; Flamme et al. 
1998), stimulating tissue remodeling by inducing angiogenesis (Nissen et al. 1998) and 
vascular permeability (Venkatraman & Claesson-Welsh 2019). It also contributes to wound 
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healing by its anti-inflammatory properties (Lapeyre-Prost et al. 2017). In cancers, VEGF is 
known to play an important role in tumor metastasis (D. Zhang et al. 2010). 
HIF-2α signaling induces expression of factors important for chronic adaptation to hypoxia, 
such as cell proliferation, erythropoiesis and tissue remodeling (S. A. Patel & Simon 2008). 
For example, cell proliferation is driven by HIF-2α induction of TGFα expression and c-Myc 
activity (Zhao et al. 2014; Gordan et al. 2007). To maximize O2 delivery, HIF-2α promotes 
erythropoiesis by driving gene expression of erythropoietin (Rankin et al. 2007).  Arginase 1 
and 2 (Arg-1 and Arg-2) are examples of known HIF-2α targets that contribute to tissue 
remodeling (Chen et al. 2009; Cowburn et al. 2016; Grasemann et al. 2015; Maarsingh et al. 
2011). These enzymes convert L-Arginine to L-ornithine and are found in various tissues and 
cells (Caldwell et al. 2018). Although involved in many different pathological conditions, these 
enzymes are known to contribute to hypertension by inhibiting NO production through L-
arginine depletion (Huynh et al. 2009; Takeda et al. 2010; Cowburn et al. 2016). Furthermore, 
this mechanism is also important for wound repair, as decreasing NO is necessary to protect 
the tissues from damage (Kämpfer et al. 2003).   
For example, high-altitude Tibetan populations are reported to have increased peripheral blood 
flow and NO production (Erzurum et al. 2007), while Arg-2 has been found to be essential for 
development of hypoxia induced pulmonary hypertension (Cowburn et al. 2016).  Overall, 
HIF-1α and HIF-2α initiate signaling pathways that are important for cellular responses in acute 
and chronic hypoxia. These examples only mention conditions driven by environmental 
hypoxia and cardiovascular adaptations to hypoxic situations. However, any motile cells that 
need to move between different organs and tissues are required to handle rapid changes in O2 
levels (Palazon et al. 2014). Myeloid cells are present in all types of tissues and are extremely 
motile (Bassler et al. 2019). The need for myeloid cells to move into different environments is 
also creating the need for them to be able to handle rapid changes in O2 levels (Bassler et al. 
2019), explaining why HIF-1α and HIF-2α are essential factors for their function (Aragones et 
al. 2011). 
 
1.4 PHAGOCYTOTIC MYELOID CELLS 
Cells of the myeloid cell lineage are classically described as cell types that originate from 
common myeloid progenitors (Weiskopf et al. 2016). These cells consist of megakaryocytes, 
erythrocytes, granulocytes, monocytes, macrophages and dendritic cells (Weiskopf et al. 2016). 
Phagocytotic myeloid cells (PMC) are a subgroup within the myeloid lineage responsible for 
clearance of infected and inflamed tissues, as well as for the the activation of adaptive immune 
system through antigen presentation and cytokine production (Hünniger & Kurzai 2018; H. 
Liu & Pope 2004; Grabowska et al. 2018). PMCs include neutrophils, monocytes, 
macrophages and dendritic cells (Hünniger & Kurzai 2018). Neutrophils have several unique 
functions and phenotypes, such as being polymorphonuclear, to be first to respond at the site 
of an infection and the ability to produce neutrophil extracellular traps (Papayannopoulos 2017; 
Kumar et al. 2018). Macrophages, monocytes and dendritic cells share a significant amount of 
functional and phenotypic properties, despite differences in origin (Guilliams et al. 2014). 
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Tissue resident macrophages originate from prenatal stages of development, while circulating 
monocytes develop from hematopoietic stem cells (Davies et al. 2013). Despite the different 
origin, monocytes are known to differentiate into inflammatory antigen presenting phagocytes 
with abilities to promote and inhibit further inflammatory responses (Guilliams et al. 2018). 
Dendritic cells and macrophages have long been considered as different cell types, however, 
plasticity of these cells is predominant as their properties vary with their localization and 
environment (Bassler et al. 2019). Furthermore, phenotypical and functional similarities 
between these cells complicate their classification (Gottschalk & Kurts 2015). 
Multidimensional technologies, such as single cell sequencing and cytometry by time‐of‐flight 
further contribute to the complexity and challenges of classifications in the myeloid 
compartment (Günther & Schultze 2019), resulting often in more complex classification 
(Bassler et al. 2019). Because of this, monocytes, macrophages and dendritic cells will be 
henceforth referred to as mononuclear phagocytes (MP). Functionally, MPs can be described 
as a multi-tool cell type (Figure 5). In tissues, MPs function as sentinel cells because of their 
capability to recognize damage and pathogen associated molecular patterns, furthermore they 
recruit other cells to the sites of the infection or damage (Stegelmeier et al. 2019; Peiseler & 
Kubes 2018). In case of infections, MPs clear the infected tissues by phagocytosis and activate 
the adaptive immunity through antigen presentation and pro inflammatory cytokines 
production (Kugathasan et al. 2008; Kashem et al. 2017). They also contribute to adaptive 
immunity by phagocytosing antibody bound pathogens (W. He et al. 2017). As the infection or 
tissue damage progress into tissue repair, MPs drive this process through secretion of anti-
inflammatory cytokines, growth factors (Wynn & Vannella 2016) and clearance of dead cells 
(Nagata 2018). A broad range of MP functions are dependent on HIF signaling as inflammation 
and hypoxia are coexisting factors (Palazon et al. 2014).  
 
 
Figure 5: There are several cell types within myeloid phagocytes, however most of these cell types share similar 
functions. 
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2 MYELOID CELL HYPOXIA IN DISEASE 
 
The importance of HIF signaling in MP function could best be described by their ability to 
induce HIF stabilization in an O2-independent manner. O2-independent stabilization of HIF-1α 
in MPs occurs upon recognition of both gram-positive and gram-negative bacteria 
(Peyssonnaux et al. 2005; Hartmann et al. 2007). HIF-1α stabilization is found to be essential 
for bactericidal ability of MP, while the deletion of myeloid HIF-1α enhances murine 
vulnerability to bacterial infections (Peyssonnaux et al. 2005). Earlier studies demonstrated that 
lipopolysaccharides (LPS), an endotoxin found on the surface of gram-negative bacteria, 
triggers HIF-1 expression and stabilization in MPs through toll like receptor 4 (TLR4) (Blouin 
et al. 2003). Besides LPS, the stimulation of MPs by TNFα and IFNγ induces stabilization of 
HIF-1α, while IL-4 stimulation, results in stabilization of HIF-2α (Albina et al. 2001; Takeda 
et al. 2010). Furthermore, inflammatory regulated and O2 independent stabilization of HIF-1α 
has been found to be triggered by HIF-1α and NF- κB interaction (Rius et al. 2008). 
O2-independent stabilization of HIF during different functions of MP demonstrates an 
interconnection with HIF signaling. This interconnection plays a significant role in different 
diseases. For instance, deletion of HIF-1α in myeloid cells reduces clinical symptoms of 
experimental arthritis due to loss of MPs’ migratory ability to the site of inflammation (Cramer 
et al. 2003). HIF-1α has been suggested to play a role in atherosclerosis, as MPs stabilize HIF-
1α upon recognition of a low-density lipoprotein (Shatrov et al. 2003). Acute lung injuries 
caused by bacterial or parasite infections are attenuated in absence of MP-HIF-1α (Huang et 
al. 2018; Cahayani et al. 2016). Similar observations have been made in asthma induced tissue 
remodeling and airway resistance (Alexander et al. 2012; Byrne et al. 2013). In other 
experimental diseases, complete removal of MP-HIF-1α and HIF-2α signaling deprives the 
ability to resolve experimental colitis in mice (N. Lin et al. 2018). 
 
2.1 HIGH ALTITUDE PULMONARY EDEMA 
Rapid ascent to high altitudes exposes subjects to sudden environmental hypoxia, which in turn 
will result in extensive HPV and activation of chemoreceptors in the lung and bloodstream 
(Bandopadhyay & Selvamurthy 2000). These signaling pathways cooperatively trigger 
hyperventilation, tachycardia, increased cardiac output and pulmonary hypertension (Weir et 
al. 2005).  Prolonged exposure to high altitude induces normalized cardiac output, decreased 
stroke volume, tachycardia, hyperventilation and development of pulmonary hypertension 
(Siebenmann & Lundby 2015). Sustained pulmonary hypertension, in turn, leads to an 
increased extravascular fluid in the lung, advancing to pulmonary edema (Stream & Grissom 
2008).   
High altitude pulmonary edema (HAPE) is a hypoxia induced noncardiogenic pulmonary 
edema. Reported incidence of HAPE varies depending on region and population, typically from 
0.18% to 5.2% (M Maggiorini et al. 1990; Apte et al. 2014). Although low in incidence, 
 12 
untreated HAPE may be lethal (Wilkins et al. 2015). HAPE is manifested as shortness of 
breath, cough and reduced physical activity, tachycardia and moderate fever (Stream & 
Grissom 2008). The pathogenesis of HAPE is initiated by extensive HPV, not all cases of 
extensive HPV progress into HAPE (Dehnert et al. 2015).  
Several studies revealed genetic polymorphisms associated with a predisposition for HAPE 
(Luo et al. 2012; Eichstaedt et al. 2020). Some of these genetic variations have been identified 
in genes encoding for the glucocorticoid receptors and the proinflammatory cytokine IL-6, 
proposing a role of inflammation in HAPE (Yang et al. 2019; X. He et al. 2018). Transcriptional 
analysis from HAPE affected persons presented upregulation of genes mainly involved in 
vascular remodeling and chronic inflammation (Sharma et al. 2014; Yuhong et al. 2018). In 
addition, inflammation has been demonstrated as a risk factor for HAPE has been demonstrated 
in early studies (Durmowicz et al. 1997). Some variants of human leukocyte antigen (HLA) 
were associated with HAPE susceptibility (Hanaoka et al. 1998). Furthermore, increased levels 
of pro-inflammatory cytokines (e. g. IL-1, IL6 and TNF) and inflammatory cell numbers were 
found in alveoli of subjects suffering from HAPE (Kubo et al. 1998). Serum levels of MP 
associated cytokines CCL2 and CCL3, were elevated in individuals with a history of HAPE, 
these were presumably residues from a chronic inflammation (Mishra et al. 2015). Trials with 
the anti-inflammatory corticosteroid Dexamethasone were successful in treating HAPE (Marco 
Maggiorini et al. 2006; Jones et al. 2012). Experimental models of hypoxic pulmonary 
hypertension confirm the observations found in humans. Rats exposed to chronic hypoxia 
showed increased pulmonary levels of proinflammatory cytokines: CXCL12, IL6, and CCL2, 
accompanied by accumulation of MPs at the site of tissue remodeling (Burke et al. 2009). 
Depletion of MPs in murine models blocked tissue remodeling and development of hypoxic 
pulmonary hypertension (Vergadi et al. 2011). Genetical removal of inflammatory signal 
transduction proteins, receptor IL-1R and adaptor MyD88, in myeloid cells damped the 
progression of hypoxic pulmonary hypertension (Parpaleix et al. 2016). Furthermore, myeloid 
deletion of HIF-1α results in protection against hypoxia-induced pulmonary tissue remodeling 
(Kojima et al. 2019). 
 
2.2 CANCER AND METASTASIS 
Cancer is the second most common cause of death worldwide. Approximately 17% of global 
deaths in 2017 were due to cancer (Collaborators et al. 2018). This is a group of diseases 
initiated by genetic mutations promoting uncontrolled cell proliferation (Fouad & Aanei 2017). 
The high mutation frequency enables cancer cells to acquire new traits that promote their 
survival and ability to spread (Fouad & Aanei 2017). In a tumor, cancer cells shape their 
environment and surrounding cells to form the tumor microenvironment (TME) (Hui & Chen 
2015). This process is also known to occur in distant tissues, creating pre-metastatic niches 
before the arrival of cancer cells (Peinado et al. 2017). Rapidly growing tumor masses result in 
increased O2 consumption and underdeveloped blood perfusion, resulting in tumor tissue 
hypoxia (Muz et al. 2015). Even though cancers are heterogeneous hypoxia is present in most 
solid cancer types (Figure 6) (McKeown 2014). Another major component of TME are MP 
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(Kather et al. 2018). Their presence is found in the majority of solid tumors (Kather et al. 2018). 
Hypoxia and MPs are some of the most important driving forces in TME and cancer 
progression (A. Patel & Sant 2016). Both of these features are associated with poor prognosis 
(Walsh et al. 2014; Qian & Pollard 2010).   
In murine models of cancer, genetic depletion of MPs did not have any impact on primary 
tumor growth, but it reduced the metastatic progression of these tumors (E. Y. Lin et al. 2001). 
Likewise, pharmacological inhibition of colony-stimulating factor receptor 1 (CSFR1) an 
essential receptor for MP differentiation and proliferation, resulted in reduction of growth and 
progression in murine models of cervical, breast and prostate cancer as well as glioma 
(Strachan et al. 2013; Pyonteck et al. 2013; Xu et al. 2013). CSFR1 inhibitors are currently in 
several clinical trials, where some demonstrated a modest clinical benefit (Cannarile et al. 
2017), suggesting a more advanced role of MP in cancer progression.   
 
Figure 6: Oxygen levels found in different types of cancer (red) compared to physiological levels in healthy 
tissue (gray). Data collected from (McKeown 2014) 
 
Myeloid cell HIF signaling plays an important, yet complex, role in cancer.  Deletion of 
myeloid HIF-1α leads to decreased tumor growth in a spontaneous mouse models of breast 
cancer (Doedens et al. 2010) and to decreased development of obesity-associated liver cancer 
(Takikawa et al. 2019). Similar observations have been made in chemically induced 
fibrosarcomas, where mice lacking myeloid HIF-1α are less likely to develop tumors (Henke 
et al. 2016). However, in other cancer models, such as colitis associated cancer and syngeneic 
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models of breast cancer, removal of myeloid HIF-2α resulted in reduced tumor formation and 
growth (Imtiyaz et al. 2010; Susen et al. 2019). Furthermore, in the latter example, deletion of 
myeloid HIF-1α had no effect on tumor growth (Susen et al. 2019). As benefits in deletion of 
myeloid HIF-1α and HIF-2α may vary depending on the mouse model, most of the HIF 
signaling target genes in myeloid cells have shown to contribute to tumor progression (Henze 
& Mazzone 2016).   
CCL2, a cytokine important for recruiting lymphocytes and myeloid cells at the site of infection 
(Gschwandtner et al. 2019), is induced by hypoxia and HIF-1α signaling (Mojsilovic-Petrovic 
et al. 2007). Both myeloid cell and cancer cell production of CCL2 is known to drive the tumor 
progression in all steps; from stimulating tumor growth to driving metastatic spread, by 
assisting cancer cells in extravasation and intravasation (Lim et al. 2016). Another hypoxia-
induced cytokine, IL-6 (Peyssonnaux et al. 2007), is known to protect cancer cells by 
stimulating cancer cell resistance against chemotherapy (Kumari et al. 2016; Long et al. 
2017).   
Cyclooxygenase-2 (COX-2) is a driver of cancer promoting inflammation through production 
of prostaglandins (B. Liu et al. 2015). COX-2 activity promotes tumor immune evasion by 
regulating both innate and adaptive immune system (B. Liu et al. 2015). HIF-1α activity 
directly induces COX-2 expression (Kaidi et al. 2006), while COX-2 expression induces both 
HIF-1α and HIF-2α stabilization (Li et al. 2015; Dong et al. 2018). Inhibition of COX-2 has 
shown clinical benefits in colorectal cancer (Steinbach et al. 2000) and it is known to improve 
radiotherapy in other cancers (Salehifar & Hosseinimehr 2016). Although cancer cells express 
a large amount of COX-2, it has been reported that myeloid cell COX-2 activity can drive up 
the activity of COX-2 in cancer cells (Li et al. 2015).  
Several classical HIF-1α and HIF-2α targets in MPs contribute to angiogenesis, endothelial cell 
permeability and MP driven immuno-suppression (Figure 7). Removal of myeloid VEGF 
resulted in increased tumor growth due to normalized vasculature, however, normalized 
vasculature also made the tumors more sensitive to chemotherapy (Stockmann et al. 2008). In 
breast cancer models, myeloid deletion of VEGF and anti-VEGF treatment reduces seeding 
and growth of lung metastasis (Bonapace et al. 2014; Qian et al. 2011). Deletion of Arg-1, a 
HIF-2α target, reduces tumor growth in a lung cancer isograph model (Colegio et al. 2014).  MP 
HIF-1α drives T-cell suppression through myeloid-secreted NO (Doedens et al. 2010) and 
increased expression of Programmed death-ligand 1 (PD-L1) (Noman et al. 2014). Increased 
expression of NOS2 in combination with COX2 is associated with low survival in patients with 
triple negative breast cancer (Basudhar et al. 2017). Furthermore, targeting iNOS together with 
immune-checkpoint blockade therapy has been suggested as a potential co-treatment strategy 
(Ekmekcioglu et al. 2017). Independent of MP, cancer cell HIF-1α is known to directly 
influence cancer cell antigen presentation by downregulation of Major histocompatibility 
complex (MHC) Class I (Sethumadhavan et al. 2017). 
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Figure 7: Several direct targets of HIF activity contribute to the major parts of cancer progression.  
 
2.3 SEPSIS 
Worldwide, approximately 48.9 million cases of sepsis and 11 million sepsis related deaths 
have been reported in 2017, this represents approximately 19.7% of total global deaths during 
the same year (Rudd et al. 2020). Usually, sepsis is caused by an ongoing infection in the 
respiratory tract (Vincent et al. 2009). Originally, it was separated into four different groups; 
systemic inflammatory response, sepsis, severe sepsis and septic shock (Lever & Mackenzie 
2007), described in order of severity and progression. Current definition of sepsis is divided 
into two subgroups; sepsis and septic shock. Sepsis is diagnosed by hyperventilation, low blood 
pressure and decreased consciousness; while septic shock is diagnosed with hypotension, 
hypoxemia and increased serum lactate levels (Singer et al. 2016). Diastolic dysfunction in 
patients with severe sepsis is often associated with a high mortality rate (Brown et al. 2012). 
At this stage, failed perfusion of peripheral organs will lead to multi organ failure (Gotts & 
Matthay 2016). Besides the ongoing hypoxemia and decreased peripheral perfusion, O2 
consumption and resting metabolic rates are decreasing as the level of severity increases 
(Kreymann et al. 1993). 
In a typical development of sepsis, infectious bacteria will enter the bloodstream causing a 
cytokine storm by triggering the innate immune system (Stearns-Kurosawa et al. 2011). In most 
cases where sepsis is caused by gram-negative bacteria (Vincent et al. 2009), the cytokine storm 
is triggered by MP TLR4 recognition of LPS, localized on the bacterial surface (Jang et al. 
2017). Although MPs are the major contributors to the cytokine storm in sepsis (Karakike & 
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Giamarellos-Bourboulis 2019), their depletion and defects worsen the outcome in sepsis (Lee 
et al. 2020; Traeger et al. 2008; D. Liu et al. 2018) 
The circulatory and respiration defects during sepsis result in tissue hypoxia (Loiacono & 
Shapiro 2010). In most bacterial infections, HIF-1α has a protective role (Devraj et al. 2017), 
while in sepsis, HIF-1α may contribute to progression of the disease (Vanderhaeghen et al. 
2020), as MP and hypoxia signaling are closely connected. MP recognition of LPS leads to 
hypoxia independent upregulation of HIF-1α (Nishi et al. 2008; Frede et al. 2006; Peyssonnaux 
et al. 2007). In vivo, myeloid specific deletion of HIF-1α improved survival of mice treated 
with LPS. Furthermore, serum levels of IL-12 and IL-1β were lower in mice lacking myeloid 
HIF-1α, compared with wildtype controls (Peyssonnaux et al. 2007). HIF-1α induction of IL-
1β was later found to be succinate-dependent (Tannahill et al. 2013). Other studies confirmed 
the importance of HIF-1α in sepsis. Treatment of mice suffering from LPS or cecal ligation 
and puncture (release of fecal material into the peritoneal cavity) induced  sepsis with 2-
methoxyestradiol (a metabolic inhibitor of HIF-1α) enhanced their survival and reduced signs 
of acute lung injuries (Yeh et al. 2011). Similarly, MP specific HIF-2α knockout mice also 
showed an increased survival rate, reduction in cytokine production and preserved cardiac 
function during the LPS challenge (Imtiyaz et al. 2010). Transcriptomic analysis of PBMC 
from 265 patients suffering from sepsis revealed two types of sepsis response signatures with 
different mortality rates. The group of patients with a higher mortality rate had higher 
expression of HIF-1α and HIF-2α (Davenport et al. 2016).  After an infection, the immune 
system enters an immune suppressive stage to protect tissue from further damage and initiate 
healing; a stage also known as endotoxin tolerance (D. Liu et al. 2018). Endotoxin tolerance 
followed by sepsis is usually associated with high risks of secondary infections (López-Collazo 
& Fresno 2013). HIF-1α has been found to contribute to endotoxin tolerance in MP by 
upregulation of the immunosuppressive surface protein PD-L1 (Avendaño-Ortiz et al. 2017).   
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3 AIMS 
The aim of this thesis is to understand the function and role of myeloid cell hypoxia. This 
includes understanding the effects on the myeloid functions and their involvement in 
pulmonary physiology. Furthermore, studies included in this work investigate the role of 
myeloid hypoxia in major diseases.  Specifically, this thesis aims to:  
I. Understand the role of myeloid cell hypoxia in pulmonary physiology and their 
influence on pathological events leading to high altitude pulmonary edema. 
 
II. Deepen the understanding of HIF signaling in myeloid cell-driven activation of 
adaptive immune-response in cancer and overall influence of deregulated hypoxia 
signaling in myeloid cells. 
III. Gain deeper knowledge on how myeloid HIF-1α contributes to the pathogenesis of 
sepsis 
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4 MATERIALS AND METHODS 
 
This section focuses on materials and methods used to perform experiments from the results 
section “Complementary data” (unpublished data). Detailed information about methods 
involving paper I, II and III can be found in the respective articles/manuscripts. 
4.1 ANIMAL MODELS 
Myeloid-specific knockout mice targeting genes involved in hypoxia signaling were used. 
These models were generated through crossbreeding mice carrying genes of interest flanked 
with LoxP sites (GOIfl) with transgenic mice expressing Cre recombinase under the lysozyme 
M promoter (Clausen et al. 1999). Experimental litters consist of phenotypically wild type mice 
homozygous for flanked genes (GOIfl/fl) and myeloid specific knockouts homozygous for 
flanked genes and hemizygous for Cre (GOIfl/fl LysMCre). Cre recombinase driven by the LysM 
promoter (LysMCre) have been reported to be efficiently expressed in neutrophils and 
macrophages, and to a lesser extent in other myeloid cells, such as monocytes, dendritic cells 
and granulocytes are also affected (Abram et al. 2014).  
 
4.2 CANCER MODELS 
The murine model of spontaneous breast cancer was acquired through breeding VHLfl/fl 
LysMCre mice with C57/Bl6 mice hemizygous for mammary tumor driven by Polyoma Virus 
middle T antigen (MMTV-PyMT). The age of onset was determined when the first palpable 
tumor was detected, while the age of death was determined by the humane endpoint of tumor 
size equal to 1000 mm3. At this point tumor and lung tissues were collected for histological 
assessment of metastasis.  
Lewis lung carcinoma (LLC) cell line expressing green fluorescent protein (GFP) were used 
for orthotopic tumor models (LLCGFP) (Branco-Price et al. 2012). Mice aged 11-13 weeks were 
injected subcutaneously with 500 000 cells LLCGFP. Tumor size was measured with a caliper 
three times per week. In order to study the metastatic establishment in our mouse models, 
200 000 LLCGFP cells were injected intravenously through the tail vein. Lungs were collected 
three weeks later. The number of metastasis and the metastatic burden were established through 
histological assessment.  
In order to determine the time dependent dynamics of immunological populations in the lungs 
during establishment of metastasis, mice were injected with 200 000 LLCGFP intravenously 
followed by collection of lungs at 2, 7, 14 and 21 days post injection. Lungs were then 
processed and analyzed by flow cytometry in a similar manner as previously reported 
(Gojkovic et al. 2020; Fitzpatrick et al. 2018).  
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4.3 CLODRONATE TREATMENT 
LysMCre mice with Cre dependent tdTomato expression (tdTomato LysMCre) were injected 
with liposomes (containing clodronate or PBS) intraperitoneally twice, with a 72 hour gap 
between the injections. Lungs were perfused, collected and analyzed 24 hours after the last 
injection. Permeability assay for clodronate treated VHLfl/fl LysMCre was performed as reported 
previously (Gojkovic et al. 2020) 
 
4.4 TRANSCRIPTOMICS 
Bone marrow-derived myeloid cells (BMDM) were prepared from VHLfl/fl and VHLfl/fl 
LysMCre bone marrow as previously reported (Gojkovic et al. 2020). Mature BMDM were then 
cultured in three different conditions, cultured either in media alone (untreated group), 10 
ng/mL TNF and INFγ or 10 ng/mL IL4 and IL13. 48 hours after the treatment, cells were 
collected and lysed using RNeasy Plus (Qiagen, cat nr: 73404) lysis buffer according to the 
manufacturer’s instruction. Sample lysates were then sent off for further analysis and RNA 
sequencing. Statistical analysis of acquired transcriptomics data was done with iDEP (Ge et al. 
2018). 
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5 RESULTS AND DISCUSSION 
 
5.1 PAPER I: DEREGULATED HYPOXIA SIGNALING IN PULMONARY EDEMA 
Inflammation contributes to pathogenesis of HAPE (Kaminsky et al. 1996; Durmowicz et al. 
1997). As described earlier, individuals suffering from HAPE demonstrated increased levels 
of proinflammatory cytokines in bronchoalveolar lavage (BAL) and blood (Mishra et al. 2015; 
Kubo et al. 1998). Studies in animals revealed a recruitment of myeloid cells to the pulmonary 
site in early exposure to hypoxia (Vergadi et al. 2011). Our study demonstrated that myeloid 
cell hypoxia contributes to an important role in HAPE pathogenesis. Measuring wet and dry 
lung weights revealed that mice lacking myeloid VHL had increased levels of pulmonary fluid. 
Signs of endothelial cell fenestration and increased pulmonary permeability in VHLfl/fl LysMCre 
mice revealed a spontaneous development of pulmonary edema (Figure 8). 
 
Figure 8: Deletion of myeloid VHL results in pulmonary edema. (A) Total lung weights in grams, dehydrated 
lung weight and lung fluid mass calculated as a difference between total lung weight and dry weight. (B) 
Representative electron microscope pictures demonstrating detached endothelial cell layer (endothelial 
fenestration) in VHLfl/fl LysMCre mice. (C) Pulmonary endothelial permeability measured by quantification of 
Evans blue entering alveolar space from the blood stream. Data presented as Tukey boxplots, * P < 0.05,  
** P < 0.01, ns = not significant. Statistical analysis was performed with unpaired T test, n = 7–8 mice per group.  
 
Further on, the immunological characterization of BAL in VHLfl/fl LysMCre showed a similar 
profile as described in individuals suffering from HAPE. However, a similar assay performed 
on the whole lung demonstrated opposite results, showing decreased numbers of alveolar 
macrophages, where data from BAL had a clear increase in numbers of alveolar macrophages. 
In the literature, human studies are focused on the components of BAL or blood serum, as 
pulmonary biopsies are associated with severe risks (Yeow et al. 2004), therefore leaving little 
data to compare our findings with clinical cases. The transcriptomic data in our study showed 
an upregulation of several genes that are known to disturb cell-to-cell adhesion, suggesting that 
increased amount of alveolar macrophages in VHLfl/fl LysMCre mice caused the difficulties of 
alveolar macrophages to attach to the surface of the alveolar epithelium.  
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Reduced physical performance has been reported as a symptom of HAPE (Stream & Grissom 
2008). Exposing mice to voluntary running revealed a slight reduction in time spent running. 
Yet, a strong reduction in covered distance and speed could be observed. Echocardiography in 
resting mice showed a decreased stroke volume, with unchanged cardiac output. Reduced 
stroke volume (SV) has previously been observed in HAPE, similar to our observations (Gupta 
et al. 2016). Reduction of SV could be explained by the increased vascular resistance in the 
lungs causing a reduced pulmonary venous flow to the heart, explaining why less blood will 
reach the peripheral tissues in each pulsation of the heart. The reduced peripheral blood flow 
will result in less O2 reaching the muscles, which are required for any physical exercise (Figure 
9). 
Figure 9: Myeloid hypoxia signaling results in reduced stroke volume and physical performance. (A) Stroke 
volume measured on resting mice by echocardiography. (B) Mice were housed with running wheels monitoring 
daily activity, distance and speed of running.  Data presented as Tukey boxplots and xy graphs with standard 
deviation, * P < 0.05, **P <0 .01. Statistical analysis was performed with unpaired T test, n = 8–10 mice per group, 
2 mice/wheel.  
 
Cellular adaptation to hypoxia through HIF-1α and HIF-2α involves transcription of numerous 
genes (Dengler et al. 2013) and therefore requires a wide approach in understanding the biology 
of myeloid hypoxia in the pulmonary tissue. Concerning this, we performed RNA-sequencing 
of whole lungs from VHLfl/fl and VHLfl/fl LysMCre mice. Deletion of myeloid VHL resulted in 
transcriptional changes of more than 400 genes. Many of these are known to be involved in 
endothelial permeability, regulation of blood flow and inflammatory processes, showing a 
complex contribution of HIF signaling in HAPE (figure 10). 
 
Figure 10: GO pathway enrichment analysis of VHLfl/fl vs VHLfl/fl LysMCre. Adjusted P Value presented as 
negative Log10.  
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The environmental hypoxia of high-altitude triggers extensive pulmonary vasoconstriction, 
causing hypertension and increased vascular permeability, ultimately resulting in pulmonary 
edema. Simultaneously, alveolar hypoxia will trigger a cellular hypoxic response mediated 
through HIF activity. Several factors downstream of HIF will drive the inflammatory response, 
vascular permeability (inflammation itself is known to trigger both vascular permeability and 
HIF activity) and edema. In a nutshell, both cellular and vascular adaptations to hypoxia will 
drive events leading to pulmonary edema.  
In our mouse model the chain of events leading to pulmonary edema is by myeloid cell HIF 
signaling. As our data demonstrated, factors driving inflammation, such as receptors Trem2, 
Cx3cr1 and chemokine Cxcl15 will contribute to events leading to vascular permeability. 
However, other genes controlled by HIF signaling, such as Spock1, Serpine1 and Mmp12, will 
cause vascular permeability directly. Bypassing pulmonary vasoconstriction, myeloid hypoxia 
itself will drive the pathological events similar to those in HAPE (Figure 11).   
 
Figure 11: Illustrations of pathological events leading to HAPE in humans vs VHLfl/fl LysMCre mice with an 
activated hypoxic response in myeloid cells, causing an VHLfl/fl LysMCre HAPE-like edema and bypassing the 
pulmonary vasoconstriction.  
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5.2 PAPER II: MYELOID NITRIC OXIDE BLOCKS CYTOTOXIC T-CELL 
PROLIFERATION 
Infections and cancers are mainly resolved through antigen recognition of cells from the 
adaptive immune system. However, in order to activate the adaptive immune response, these 
cells require antigen presentation through antigen presenting cells (APC). Tissues are 
constantly cleared from dead cells through myeloid cell phagocytosis. Cellular debris are 
processed, and parts of proteins presented on the surface of the myeloid cell. (Guermonprez et 
al. 2002). In cancer, APC activation of cytotoxic CD8 T cells is an essential part of tumor 
clearance by the immune system (Broz & Krummel 2015). After engulfing cancer cell debris, 
an APC will present cancer neoantigens, a byproduct of non-synonymous mutations, on its 
surface through MHC Class I and Class II (Reeves & James 2016). By recognition of 
neoantigens, presented through MHC Class I, CD8 T cells with a compatible T-cell receptor 
(TCR) will become activated and mature into a cytotoxic T-cell (Guermonprez et al. 2002), a 
process accompanied by clonal expansion. Several factors in the tumor microenvironment are 
known to have a negative impact on APC-dependent CD8 T-cell activation (Fu & Jiang 2018), 
many of which are driven by hypoxia and HIF signaling (Vaupel & Multhoff 2018).  
In order to understand how a hypoxic environment influences the APC ability to activate 
cytotoxic T cells, we monitored hypoxic antigen presentation in vitro. This was done by 
activation of BMDMs with LPS, followed by introduction of an MHC class I-restricted antigen 
(SIINFEKL) of chicken ovalbumin (OVA), and co-cultured with OVA-specific CD8 T Cells 
(OT-I), as illustrated in Figure 12. The BMDM and OT-I co-culture was then performed under 
atmospheric oxygen conditions (21% O2) or hypoxic conditions (5% or 1% O2) 
 
Figure 12: A schematic overview of the antigen presenting assay.  Bone marrow myeloid cells (BMDM) were 
activated with LPS followed by antigen loading and introduction of antigen specific T-cells, for details please 
see paper II.  
 
Initially, cultures of OT-I cells alone did not demonstrate any changes in ability to divide and 
proliferate after activation with antigen when cultured in hypoxic conditions. However, when 
OT-I cells were activated through BMDM antigen presentation, hypoxia blocked their ability 
to divide and proliferate. While performing the antigen-presenting assay in 21% O2 with 
BMDMs lacking VHL resulted in a similar outcome as observed in hypoxic conditions, thus 
indicating that hypoxia signaling in myeloid cells is responsible for the blockade of T-cell 
division and proliferation (Figure 13).  
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Figure 13: Myeloid cell hypoxia blocks antigen induced T-cell proliferation. Representative figures of 
CellTrace™ Violet Cell Proliferation stain (CTV), where each peak occurring on the left side represents a cell 
division comparing single cultures of T cells (top row) or cocultured with antigen presenting BMDMs (bottom 
row).  
 
In order to understand the mechanism through which myeloid hypoxia is blocking OT-I 
division and proliferation, a series of antigen-presenting assays were performed with BMDMs 
lacking HIF-1α, HIF-2α, Arg-1, Arg-2 or NOS2.  
In summary (as illustrated in Figure 14), deletion of myeloid HIF-1α or iNOS rescued OT-I 
ability to divide and proliferate. Furthermore, removal of myeloid HIF-1α and iNOS resulted 
in higher expression levels of T-cell activation markers, such as Granzyme B and CD44, 
suggesting that myeloid- NO blocks T-cell activation. To confirm this, T cells were cultured 
with different doses of a NO donor, diethylenetriamine (NOC-18). Both division and 
proliferation of activated T cells were blocked by NOC-18 in a dose dependent matter (Figure 
4, Paper II).  
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Figure 14: Myeloid cell HIF-1α driven production of NO blocks antigen induced T-cell proliferation. 
Representative figures of CellTrace™ Violet Cell Proliferation stain (CTV) comparing T-cell proliferation induced 
by wild type or knockout BMDMs in 21% vs 1% oxygen. Bottom figure compares BMDM treated with vehicle 
vs 12,5 µM FG4592 in 21% oxygen.  
 
In order to investigate the significance of myeloid cell NO in vivo, NOS2fl/flLysMCre mice were 
injected in the tail vein with a melanoma cell line expressing OVA (B16-F10-OVA). By using 
a metastatic model of melanoma, we were able to observe both the ability of cancer 
establishment and growth in lungs. Mice lacking myeloid NOS2 had fewer metastatic foci with 
no difference in size.   
Other studies have demonstrated that myeloid cell blockade of already activated T-cells is NO- 
(Doedens et al. 2010; Bingisser et al. 1998) and cell contact-dependent (Rößner et al. 2005). 
However, our study confirms the link between myeloid cell hypoxia, NO and the outcome 
of colonization in the lung. Furthermore, our data suggest that the same cells presenting the 
antigen also are able to directly inhibit T-cell proliferation, which is interesting in the context 
of vaccination. Targeting tumors through vaccination against neoantigens is a potential strategy 
for future treatments (Peng et al. 2019). Furthermore, performing the antigen-presenting assay 
with a PHD inhibitor replicated the outcome seen in hypoxia (Figure 14).  
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Our data suggest that myeloid hypoxia and NO could potentially influence vaccine efficiency. 
Future studies could consist of vaccines combined with molecules inhibiting NO production in 
order to investigate if decreased amounts of NO would lead to higher efficacy of cancer 
vaccines. Another aspect for future studies would be the administration routes of vaccines. 
Perhaps, by administering vaccines in highly oxygenated tissues, such as the lungs, one could 
obtain stronger T-cell response and consequently receive a more efficient vaccine.  
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5.3 PAPER III: GLYCOLYTIC RESPONSE TO INFLAMMATION OVER TIME 
HIF-1α plays an important role in sepsis and the pathological outcome of sepsis 
(Vanderhaeghen et al. 2020). Blood pressure changes and hypoglycemia are strongly related 
to high mortality rates in sepsis (Rattarasarn 1997; Pandey et al. 2014). Previous studies in 
humans and different murine models of sepsis revealed that absence of HIF-1α signaling in 
leukocytes correlates with lower mortality rates (Davenport et al. 2016; Peyssonnaux et al. 
2007; Yeh et al. 2011). Current literature provides evidence that HIF-1α signaling in leukocytes 
and myeloid cells has an important role in pathological events during sepsis (Devraj et al. 
2017). However, little is known about the underlying mechanism and physiological impact of 
myeloid HIF-1α. Because of this, a time dependent study in a murine model of sepsis was 
performed in order to assess the role of myeloid HIF-1α in hypoglycemia and cardiovascular 
changes in sepsis.  
We showed that deletion of myeloid HIF-1α leads to a delayed hypoglycemia during early 
timepoints. MicroPet imaging with fluorodeoxyglucose (18F-FDG) revealed that most of the 
reduction in glycolysis was in the heart of HIF-1αfl/fl LysMCre mice (Figure 15). Likewise, 
metabolic changes due to deletion of myeloid HIF-1α were observed systemically, HIF-1αfl/fl 
LysMCre exhibited a minor reduction in O2 consumption and carbon dioxide production during 
the early time points post LPS injection.  
 
Figure 15: Deletion of myeloid HIF-1α delays LPS induced hypoglycemia. (A) Micro PET imaging glycolytic 
activity in whole mouse body over time. (B) Blood glucose levels in mice post LPS injection. (C) quantification 
of glycolytic activity measured with micro pet. Data represented as images, xy graphs or bar graphs.  * P < 0.05, 
** P < 0.01, *** P < 0.001. Statistical analysis was performed with two-way ANOVA and student T test, n = 7–8 
mice per group. 
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As the cytokine storm in sepsis is an essential part of its pathogenesis (Chaudhry et al. 2013); 
blood was collected at different timepoints to study changes in several cytokines. Absence of 
myeloid HIF-1α resulted in very low production of IL-6 and IL-5, while production of IL-2 
had a lower peak in HIF-1αfl/fl LysMCre compared to wild type littermates.  
Immunological characterization of the cardiac tissue revealed lower frequency of CD4 T cells 
and an increased frequency of MP in HIF-1αfl/fl LysMCre mice. Cardiovascular parameters 
measured by radio telemetry demonstrated a reduction in body core temperature, heart rate and 
diastolic blood pressure in mice lacking myeloid HIF-1α.  
Taken together, the acquired data demonstrate that myeloid HIF-1α is important during early 
events of LPS-induced sepsis. As demonstrated in Figure 16, myeloid HIF-1α is causing a time-
dependent delay in several clinical symptoms associated with sepsis. Another perspective in 
this study is the dynamics of cardiac glycolysis. The initial uptake of 18F-FDG in HIF-1αfl/fl 
LysMCre mice was abolished, while the amount of CD4 T cells was decreased in the cardiac 
tissue. Beside the increased levels of macrophages, no other changes in immunological 
populations were observed.  
 
Figure 16: Mice lacking myeloid HIF-1α have dampened development of clinical symptoms associated with 
LPS induced sepsis. (A) Body temperature, (B) heart rate, (C) diastolic and (D) systolic blood pressure.  
* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical analysis was performed with two-way 
ANOVA and student T test, n = 4 mice per group.  
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5.4 COMPLEMENTARY DATA 
This section contains data that are currently not a part of any published paper or manuscript. 
However, results from this section are complementary to this thesis. 
 
Previous studies have shown that removal of MP HIF-1α and HIF-2α resulted in delayed cancer 
development and tumor growth (Doedens et al. 2010; Susen et al. 2019). Therefore, we 
hypothesized that increased presence of HIF-1α and HIF-2α would lead to the opposite effects. 
To validate our hypothesis, we used VHLfl/fl LysMCre and FIHfl/fl LysMCre mice; where MP are 
unable to degrade  or regulate the transcriptional function of HIFs in the presence of oxygen, 
respectively. These experiments were done using a spontaneous breast cancer model MMTV-
PyMT crossed with VHLfl/fl LysMCre and a syngeneic cancer model placed on FIHfl/fl LysMCre 
mice. In the spontaneous breast cancer model, mice lacking VHL in the myeloid compartment 
did not show any difference in tumor onset, survival (Figure 17A) or tumor growth (Figure 
17B). To assess the metastatic capacity of these tumors, lungs from tumor-bearing mice were 
fixed, sectioned and stained with hematoxylin and eosin as previously described (Branco-Price 
et al. 2012). The number of metastasis or the total metastatic burden (sum of total metastasis 
per mouse) was not altered by genetic deletion of VHL in myeloid cells (Figure 17C).  
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Figure 17: Myeloid deletion of VHL does not affect cancer progression or metastasis in spontaneous breast cancer 
model MMTV-PyMT. (A) Onset and survival curves of MMTV-PyMT VHLfl/fl and MMTV-PyMT VHLfl/fl 
LysMCre mice. Date of sacrifice was determined when total tumor volume reached 1000 m3. Age of onset, 
determined when by the day when first palpable tumor was detected (n=16–18). (B) Normalized tumor weight to 
body weight at week 20 of age (n=4–10). (B) Metastatic number and burden of MMTV-PyMT VHLfl/fl and 
MMTV-PyMT VHLfl/fl LysMCre mice. Black lines within bars represent individual metastasis and space between 
them represents size in µm, each bar is an individual mouse and total height of the bar represents metastatic burden 
(n=7–11). 
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FIHfl/fl LysMCre, where MP HIF-1α and HIF-2α transcriptional activity is not suppressed by 
oxygen were injected subcutaneously with LLCGFP to assess tumor growth or intravenously in 
order to assess the metastatic spread. Neither tumor growth (Figure 18A) or pulmonary 
metastatic establishment (Figure 18B) were different between WT and KO animals. These 
experiments demonstrated that removal of FIH in myeloid cells does not influence tumor 
growth or metastasis. 
 
Figure 18: Myeloid deletion of FIH does not affect tumor progression or metastasis in mice injected with LLCGFP. 
(A) Tumor growth presented as area of tumors in mice injected with 0.5x106 LLCGFP cells subcutaneously  
(n=7–10). (B) Number of foci and metastatic burden of mice injected with 0.2x106 LLCGFP intravenously and 
sacrificed 3 weeks post injection. Metastatic burden is sum of size for all the foci/lung (um) (n=9).  
 
TME changes with different stages of cancer (Hui & Chen 2015), including the frequency and 
type of tumor-infiltrating lymphoid and myeloid cells (Kather et al. 2018). Because of this, we 
evaluated time dependent changes of myeloid and lymphoid cells in a syngeneic metastatic 
model. Lungs and spleens were collected at different time points after intravenous injection of 
LLCGFP, processed and analyzed by flow cytometry. Our analysis revealed time-dependent 
changes in several pulmonary populations after injections of LLCGFP (Figure 19). In the 
myeloid compartment, alveolar macrophages and neutrophils increased in frequency two 
respectively 21 days post injection of LLCGFP, while monocytes demonstrated a decrease seven 
days after LLC injection. B cells were the only lymphocyte population to show a significant 
change in the lungs, with a decrease two days after the injection. However, in spleens, B cells 
were increased at 21 days, whereas CD4 and CD8 T cells increased in frequency two days after 
injection and returned to basal levels at the latter timepoints. Compositional shifts of myeloid 
and lymphoid cells in metastasis at different time points reveals which cell types are important 
at different stages of metastatic development.  
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Figure 19: Dynamics of pulmonary populations within the lung post intravenous injections of GFPLLC. 
Frequencies of myeloid or lymphoid cells normalized to total number of leukocytes. Mice were injected with 
0.2x106 LLCGFP intravenously. Perfused lungs and spleens were collected at day 2, 7, 14 and 21. (n=3–5). Data 
presented as xy graphs with standard deviation, * P < 0.05, **P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical 
analysis was performed with two-way ANOVA and Tukey multiple comparison.  
 
In Paper I, we observed that removal of myeloid VHL leads to increased pulmonary 
permeability and edema. In an attempt to pinpoint the exact cell type responsible for observed 
phenotypes in VHLfl/fl LysMCre mice, we performed a depletion experiment. By injecting 
tdTomato LysMCre reporter mice with clodronate liposomes intraperitoneally, pulmonary 
CD11b+ CD11c+-MP (classically described as macrophages) subpopulation were successfully 
depleted. However, treatment with clodronate liposomes also resulted in an increased 
proportion of tdTomato-positive (LysMCre-positive) cells, where neutrophils and monocytes 
were predominant cell types (Figure 20A). Thereafter, similar clodronate treatment was 
performed on VHLfl/fl LysMCre, followed by a permeability assay. Depletion of pulmonary 
macrophages in VHLfl/fl LysMCre mice resulted in further increased pulmonary permeability 
(Figure 20B), with no differences observed between wild type littermates treated with 
liposomes carrying PBS or clodronate. The elevated permeability in clodronate treated VHLfl/fl 
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LysMCre mice is likely to be caused by increased infiltration of neutrophils and monocytes, 
compensating for the absence of macrophages. The newly recruited myeloid cells will also be 
VHL-deficient and therefore enhance pulmonary permeability through HIF signaling. 
Indirectly, the data in these experiments reinforces the link between myeloid cell hypoxia 
signaling and pulmonary permeability. 
 
Figure 20: Depletion of macrophages by clodronate liposomes increases frequency of other myeloid cells in 
the pulmonary tissues and enhances permeability induced by myeloid cells lacking VHL. (A) Frequencies of 
LysM active cells and myeloid cells normalized to total number of leukocytes. Mice were injected with 
liposomes either containing PBS or clodronate intra-peritoneally at day 0 and 3, lungs were perfused and 
collected at day 4. Dosage was 0,2 mL per mouse (n=6–7). (B) Pulmonary permeability of mice treated with 
liposomes containing PBS or Clodronate (n=4–6). *= p < 0.05, ns = not significant. Statistical analysis was 
performed with unpaired T test.  
 
HIF-1α and HIF-2α contribute to different functions of BMDM; the pro-inflammatory 
functions are driven by HIF-1α, while the anti-inflammatory functions by HIF-2α (Takeda et 
al. 2010). In order to understand the impact of deregulated HIF signaling in BMDM, RNA-
sequencing was performed on BMDM derived from VHLfl/fl and VHL LysMCre mice. This was 
done with BMDM in three different conditions: untreated, stimulated with pro-inflammatory 
cytokines (TNFα and IFNγ) and anti-inflammatory cytokines (IL4 and IL13). Comparing 
different conditions, principal component analysis revealed that cytokine treatment had a 
stronger impact on BMDM transcriptome than deletion of VHL (Figure 21A). Although 
cytokine treatments had the strongest impact on BMDM transcriptome, our aim was to 
understand the specific role of HIF signaling in each condition. Therefore, comparison of 
expressional profiles were performed between VHLfl/fl with VHL LysMCre BMDM within each 
treatment (Figure 21B), followed by comparison significant hits between the different 
treatments (Figure 21C).  
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Figure 21: Deletion of VHL in bone marrow derived myeloid cells results in differential gene expression in 
different conditions. RNA sequencing performed on bone marrow myeloid cells with different treatments. (A) Top 
three principal component analysis separating samples primarily by treatment, secondly by deletion of VHL. (B) 
Illustration of different conditions used for RNA sequencing. Differential gene expression analysis was performed 
comparing BMDMs from VHLfl/fl with VHLfl/fl LysMCre mice. (C) Venn diagram illustrating number of common 
and unique genes differentially expressed between different conditions. Cut off was done at 2-fold difference and 
FDR 0.01. n=4 
 
The largest proportion of genes that were upregulated due to deletion of VHL were shared 
between all conditions. These were genes involved in cellular processes of O2 sensing, hypoxia 
and metabolism (Figure 22). Nonetheless, deletion of VHL resulted in condition-specific 
transcription profiles. In untreated BMDM, loss of VHL resulted in upregulation of genes 
involved in inflammatory and immunological processes (Figure 23). In contrast, combination 
of VHL deletion and treatment with TNFα and IFNγ resulted in downregulation of genes 
involved in phosphorus process (kinase activity and protein phosphorylation) and upregulation 
of genes involved in negative regulation of cell proliferation and stress response (Figure 24). 
Furthermore, combination of VHL deletion and IL4 and IL13 treatment resulted in 
transcriptional changes of genes involved in cellular adhesion (Figure 25). The preliminary 
transcriptional profiling analysis on VHL knockout BMDM in different conditions shown here 
reveals that the transcriptional response to hypoxia in myeloid cells varies according to the 
stimulus applied.  
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Figure 22: Genes of hypoxia signaling are deregulated by VHL deletion in myeloid cells independent of 
culturing conditions. Log2 fold change of most deregulated genes by VHL deletion and the most significant 
GO-terms.  
 
 
 
 
 
Figure 23: Loss of VHL enhances expression of genes involved in immune response in untreated BMDMs. 
Log2 fold change of most deregulated genes by VHL deletion and the most significant GO-terms.  
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Figure 24: Loss of VHL in TNFα and IFNγ treated BMDMs preliminary deregulates genes involved in 
metabolic processes and cellular proliferation. Log2 fold change of most deregulated genes by VHL deletion 
and the most significant GO-terms analysis of downregulated and upregulated genes.  
 
 
 
 
 
Figure 25: VHL deletion in BMDMs treated with IL4 and IL13 results in altered metabolism and cell adhesion. 
Log2 fold change of most deregulated genes by VHL deletion and the most significant hits of GO enrichment 
analysis of downregulated and upregulated genes.  
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6 SUMMARY AND CONCLUSIONS 
 
Oxygen sensing in myeloid cells seems to be involved in several pathological conditions driven 
by inflammation (Palazon et al. 2014). Hypoxia and inflammation are tightly linked as most 
inflammatory conditions lead to challenged O2 delivery and increased O2 demand as recruited 
inflammatory cells increase the cellular density in the tissue (Schwartz et al. 2011). The 
inflammatory signature observed in individuals suffering from HAPE (Mishra et al. 2015) are 
an example where hypoxia itself is enough to trigger an inflammatory response. Although data 
gathered from HAPE patients does not provide enough evidence to definitely link myeloid 
inflammation to the pathological progress of HAPE, animal models and experimental 
conditions do demonstrate a strong link. The clearest examples of the link between 
inflammation and environmental hypoxia are observed in studies where removal of MP or MP 
HIF-1α in mice weakens the progression of HAPE (Kojima et al. 2019; Vergadi et al. 2011).  
Our data contributes to the evidence that links inflammation and HAPE. Removal of VHL in 
myeloid cells leads to development of HAPE-like symptoms.  Collectively, data gathered in 
our study demonstrates HAPE-like signature spanning from gene expression to physiological 
outcomes, therefore we propose that VHLfl/fl LysMCre mice could serve as a model of HAPE.   
In cancer, the literature presents a complex role of myeloid HIF-1α and HIF-2α. The 
heterogeneity of cancer itself and the discrepancy of murine models contribute to the 
complexity of current knowledge. Overall, a majority of studies om MP-HIF-1α signaling in 
cancer suggest that both MP HIF-1α and HIF-2α contribute to the progression of cancer; MP-
HIF-1α seems to be important for spontaneous development of tumors (Henke et al. 2016; 
Takikawa et al. 2019), whereas MP HIF-2α may assist in the pathogenesis of already 
established tumors (Imtiyaz et al. 2010; Susen et al. 2019). Thus, MP-HIF-1α drives the early 
establishment of tumors, while MP HIF-2α drives the later stages of cancer progression. Data 
from paper II and the complementary data included in this thesis supports MP-HIF-1α role in 
early establishment of cancer. MPs are capable to aid the adaptive immune system in clearance 
of tumors by antigen presentation. As observed in paper II, MP hypoxia and HIF-1α signaling 
blocks activation of T cells through NO. Furthermore, this process seems to be important in 
early establishment of tumor growth as removal of MP-NOS2 affects the initial establishment 
and not the growth of already established tumors. Therapeutically, removal of HIF-1α/NOS2 
signaling could potentiate the efficacy of vaccination against tumors and other diseases. 
However, drugs that activate HIF signaling might contribute to the establishment of new 
tumors by blocking the activation of the adaptive immune system.  
Complementary data demonstrates some controversy about the role of MP HIF signaling in 
cancer progression, as removal of HIF regulation does not demonstrate any effect. However, 
as a combination of cancer inflammation and hypoxia drive HIF signaling in MPs (McKeown 
2014; D’Ignazio et al. 2017), removal of FIH or VHL might not contribute to further increase 
of MP HIF signaling. Additionally, the cancer models used in our studies are known to be 
aggressive, which could potentially hide the effects of insufficient activation of the adaptive 
immune system by MPs.   
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Sepsis is another condition where a blockade of HIF signaling could serve as a possible 
therapeutic target. Earlier studies in mice have demonstrated that removal of HIF signaling 
decreases the severity of sepsis and increases the survival (Peyssonnaux et al. 2007), while in 
humans, groups with high mortality rates in sepsis have enhanced HIF expression (Davenport 
et al. 2016). Observations in Paper III suggest that targeting MP HIF-1α could potentially 
decrease organ damage caused by hypoglycemia and hypotension in septic shock. These 
observations also confirm that MP hypoxia signaling has consequences on the physiological 
level.   
HAPE, cancer and sepsis are three substantially different pathological events with their origins 
in environmental hypoxia, genetic mutations and infection. Although triggered by different 
causes, a common denominator of all three diseases is that myeloid cells in hypoxic 
environments are present, play a role and can even be the drivers of the disease progression. 
Shared signaling pathways, cytokines and physiological outcomes between these diseases 
originate from MPs and hypoxia. In this aspect, MPs and hypoxia are serving as a junction 
point for progression of HAPE, cancer and sepsis (Figure 26)  
As most junction points are complex, the role of HIF signaling in MP function is no 
exception.  Transcriptional data in figures 22-26 show that the outcome of MP hypoxia is 
stimulus dependent; expressions of more than 50 genes are condition-specific, even though 
they originate from the same genetic manipulation. Together with the plastic nature of MPs, 
more detailed studies of MP hypoxia are needed to truly understand the full potential of HIF 
signaling in myeloid cells and consequences for the physiological and pathological outcomes.  
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Figure 26: HAPE, cancer and sepsis are very different diseases with MP hypoxia as a junction point.  
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